pediatrics
October 2011, VOLUME128 /ISSUE Supplement 3

Performance of a Component-Based Allergen-Microarray in the Diagnosis of Cow's Milk and Hen's Egg Allergy

LE D'Urbano, K Pellegrino, MC Artesani. Clin Exp Allergy. 2010;40(10):15611570
  1. Edwin Kim, MD,
  2. A. Wesley Burks, MD
  1. Durham, NC

PURPOSE OF THE STUDY.

Published clinical decision points (CDPs) have improved the accuracy of current allergen-specific immunoglobulin E (sIgE) testing, but the oral food challenge (OFC) remains the gold standard. These researchers sought to evaluate the performance of an in vitro microarray-based diagnostic test for the diagnosis of cow's milk (CM) and hen's egg (HE) IgE-mediated allergy.

STUDY POPULATION.

Infants and children (N = 104; median age: 4.9 years [range: 0.7–15.1 years]) referred to the allergy clinic with a history of CM or HE consumption and a resultant severe and/or immediate reaction were included in the study.

METHODS.

Using the ImmunoCAP system (Phadia, Uppsala, Sweden), sIgE testing was performed to milk, α-lactalbumin, β-lactoglobulin, casein, egg white, and egg yolk. Microarray testing was performed to multiple known CM and HE allergen components. OFCs were performed on all subjects using pasteurized CM and boiled egg. Negative OFCs to boiled egg were followed by an OFC to raw egg. OFCs were discontinued for anaphylactic shock or objective symptoms in 2 or more systems.

RESULTS.

For CM allergy, sIgE testing to milk and casein and microarray testing to Bosd8 provided the highest accuracy for predicting OFC outcomes. For HE allergy, results of sIgE testing to egg white and microarray testing to Gald1 (ovomucoid) were most accurate. For CM allergy, the milk sIgE 95% CDP (≥16.6 kU/L) resulted in a positive predictive value (PPV) of 93% and a negative predictive value (NPV) of 57% compared with the Bosd8 microarray 95% CDP (>0.60 ISU [ISAC standardized units]), which resulted in a PPV of 96% and an NPV of 78%. For HE allergy, the egg white sIgE 95% CDP (≥25.3 kU/L) resulted in a PPV of 86% and an NPV of 59% compared with the Gald1 microarray 95% CDP (>0.86 ISU), which resulted in a PPV of 94% and an NPV of 79%. Sequential use of sIgE and microarray testing for both CM and HE yielded minimally improved results.

CONCLUSIONS.

Component-based allergen microarray provides improved PPV and NPV in the diagnosis of CM and HE allergy when compared with standard sIgE testing. The improved accuracy can reduce the number of OFCs that need to be performed and, more importantly, can reduce the number of positive challenge results, thereby decreasing the risk to patients.

REVIEWER COMMENTS.

This well-designed, prospective study found strong performance of component-based microarray testing for food allergy. However, the modest additional accuracy of microarray testing, when balanced with its limited availability and its considerable cost, limits its practical benefit. As the authors suggested, it might presently be more suited to large tertiary care centers as a secondary screen after standard specific IgE testing has been performed.